|
A more recent version of this article appeared on February 1, 2005
Papers In Press, published online ahead of print November 1, 2004
J. Lipid Res., doi:10.1194/jlr.D400014-JLR200
Submitted on July 2, 2004
Revised on October 14, 2004
Accepted on October 28, 2004
Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages
Genevieve Escher, Anh Hoang, Suzan Georges, Urbain Tchoua, Assam El-Osta, Zygmunt Krozowski, and Dmitri Sviridov
Vascular Biology, Baker Heart Research Institute, Melbourne, Vic 8008
Corresponding Author: Dmitri.Sviridov{at}Baker.edu.au
This study was aimed at developing a method for high-efficiency transient transfection of macrophages. Seven methods were evaluated for transient transfection of murine macrophage cells RAW 264.7. The highest transfection efficiency was achieved with DEAE-Dextran, however the proportion of cells expressing the reporter gene did not exceed 20%. It was subsequently found that the CMV plasmid promoter in these cells becomes methylated. When cells were treated with the methylation inhibitor 5-azacytidine, methylation of the plasmid promoter was abolished and a dose-dependent stimulation of reporter gene expression was observed with expression achieved in more than 80% of cells. Treatment of cells with 5-azacytidine also caused increased efficiency of transfection of macrophages with plasmids driven by RSV, SV40 and EF-1alpha promoters and transient transfection of human hepatoma cells HepG2. Inhibition of methylation also increased the amount and activity of sterol 27-hydroxylase (CYP27A1) detected in RAW 264.7 cells transfected with a CYP27A1 expression plasmid. Treatment of cells with 5-azacytidine alone did not affect either cholesterol efflux from non-transfected cells or expression of ABCA1 and CYP27A1. However, transfection with CYP27A1 lead to a 2-4-fold increase of cholesterol efflux. We conclude that treatment with 5-azacytidine can be used for high-efficiency transient transfection of macrophages.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Mukhamedova, G. Escher, W. D'Souza, U. Tchoua, A. Grant, Z. Krozowski, M. Bukrinsky, and D. Sviridov
Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo
J. Lipid Res.,
November 1, 2008;
49(11):
2312 - 2322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Holdt, J. Thiery, J. L. Breslow, and D. Teupser
Increased ADAM17 mRNA Expression and Activity Is Associated With Atherosclerosis Resistance in LDL-Receptor Deficient Mice
Arterioscler Thromb Vasc Biol,
June 1, 2008;
28(6):
1097 - 1103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Tchoua, W. D'Souza, N. Mukhamedova, D. Blum, E. Niesor, J. Mizrahi, C. Maugeais, and D. Sviridov
The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport
Cardiovasc Res,
March 1, 2008;
77(4):
732 - 739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Teupser, R. Burkhardt, W. Wilfert, I. Haffner, K. Nebendahl, and J. Thiery
Identification of Macrophage Arginase I as a New Candidate Gene of Atherosclerosis Resistance
Arterioscler Thromb Vasc Biol,
February 1, 2006;
26(2):
365 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|